This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Form D industry group

Biotechnology

Rounds

2

Latest round

Funding round 2026-02-18

Latest round amount

$5.0M

Total disclosed raised

$5.0Mderivedsum of disclosed round sizes only

Investors

3

People

1

Incorporated

2025

Revenue range

Decline to Discloseas stated on Form D

• Occurred

  Mar 10, 2026
  Form D filed

  Synchrony Medical Inc. filed Form D/A: $4,300,000 sold of $4,300,000, Biotechnology

  Form Dobserved 7 days ago
  $4.3M
• Occurred

  Feb 18, 2026
  Round announced

  Synchrony Medical announced Funding round of $5,000,000, led by Edge Medical Ventures

  News and newswireobserved 6 days ago
  $5.0M
• Occurred

  Sep 12, 2025
  Form D filed

  Synchrony Medical Inc. filed Form D: $1,000,000 sold of $2,500,000, Biotechnology

  Form Dobserved 7 days ago
  $1.0M

Also named here, with no published line of their own (reach them through the firm): Anat Shani (Executive Officer/Director), Eileen Ke (Director), Shai Policker (Director), Kevin Kotler (Director), Elad Dushack (Director).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Graph

Venture Capital

Canonical id

dfx:vc:080e91df-3f97-4478-b39b-f9a26896e6ca

First observed

Sep 12, 2026

Last observed

Sep 13, 2026 6 days ago

Resolution

Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.